Doug Johnson

发表

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19

A. Kornbluth, C. Siegel, B. Christensen, 2020, Journal of Crohn's & colitis.

Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.

B. Christensen, K. Bond, Aysha H Al-Ani, 2020, Digestive and Liver Disease.

Practical management of inflammatory bowel disease patients during the COVID‐19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty

S. Connor, R. Bryant, B. Christensen, 2020, Internal medicine journal.

A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia

K. Leder, P. Pentony, P. Wong, 2017, Internal medicine journal.

Review article: prevention, diagnosis and management of COVID‐19 in the IBD patient

S. Ng, D. Rubin, F. Macrae, 2020, Alimentary pharmacology & therapeutics.

SARS‐CoV‐2 vaccination in patients with inflammatory bowel disease

S. Connor, R. Bryant, B. Christensen, 2021, GastroHep.

Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19

B. Christensen, S. Fourlanos, J. Lubel, 2020, Alimentary pharmacology & therapeutics.

Letter: is pneumococcal vaccination safe during the COVID‐19 pandemic? Authors’ reply

B. Christensen, Doug Johnson, A. Al-Ani, 2020, Alimentary pharmacology & therapeutics.

P. Wong, P. Hanrahan, Doug Johnson, 2018, Internal medicine journal.

Epidemiology of long‐stay patients in a university teaching hospital

Daryl A Jones, K. Farley, J. Mårtensson, 2017, Internal medicine journal.